Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

New Treatment for Concussion with Dr. Bansal on Recovery Now with Kim Justus

  • Broadcast in Health
Brain Injury Radio

Brain Injury Radio

×  

Follow This Show

If you liked this show, you should follow Brain Injury Radio.
h:142722
s:11756229
archived

Dr. Vishal Bansal, MD. FACS  is the director of trauma surgery at  Scripps Mercy Hospital in San Diego and chief scientific officer of Oxeia BioPharmaceuticals.  As a trauma surgeon, Dr. Bansal operates on patients who are victims of a range of blunt force or penetrating traumas, from car crashes to gunshot wounds to stabbings to brain injuries. 

Dr. Bansal has seen dramatic advances in many areas of medicine, but laments that treatment for concussions is still primitive and focuses on the symptoms rather than a cure. Dr. Bansal is a physician with a dream: He wants to develop the first FDA-approved therapeutics that treat not only the immediate symptoms of a concussion, but also the underlying damage.  The company co-founded by Dr. Bansal, Oxeia Biopharmaceuticals, has a therapeutic, OXE-103 that has been approved by the FDA for Phase 2 testing.  Dr. Bansal will talk about the company’s upcoming trials and the promise of their drug for those suffering from the long-term effects of concussions.  Says, Dr. Bansal, “Rest is not enough.”

For More See:  oxeiabiopharma.com

This show is a gathering place for anyone seeking recovery from the challenges of life on life's terms. We discuss useful tools that have helped us lighten the load, of our journey through recovery. This is a "we" recovery program, because it is in the "we," that we find the new "me."

We focus on the four A's of Recovery: Awareness, Acceptance, Action and Adaptation. This is a place for survivor's striving to become thrivers, which takes a good bit of Warrior!

Hosted by Kim Justus, author of In a Flash: Miracles Here and Beyond found at inaflash.org & "Like" at facebook.com/inaflash.org

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled